More Patents Link Olive Polyphenols with Reduced Eczema, Psoriasis

August 6, 2015

Creagri has secured two new patents linking its olive polyphenol hydroxytyrosol with inflammation-related skin conditions.

Olive polyphenols (Olea europaea) are marketed for anti-inflammatory and antioxidant benefits for skin protection. Supplier Creagri Inc. (Hayward, CA) has secured two new patents linking its olive polyphenol hydroxytyrosol with inflammation-related skin conditions.

The latest patent comes courtesy of Australia (AU #2006269843 B2) and covers the use of olive polyphenols to treat inflammatory skin conditions such as psoriasis, eczema, allergic dermatitis, and others. According to Creagri, it is the company’s first patent to “relate to the correct functioning of the immune system.” It is the company’s fifth Australian patent.

In March, the European Patent Office also granted the company a similar patent (#1924269 B1) covering the use of olive polyphenols and hydroxytyrosol for the treatment of those same inflammation-based skin conditions.

Creagri’s specialty ingredient is Hidrox hydroxytyrosol. According to Victor Moreno, PhD, the company’s scientific advisor, Hidrox “is the first formulation of its kind for the management of immune-drive and inflammation-based skin disorders.” The company says previous research shows that oral intake of a hydroxytyrosol-rich supplement in daily dosages ranging from 2.5 mg–10.8 mg reduced the intensity, duration, and recurrence of flaring eczema, allergic dermatitis, photohypersensitivity dermatosis, lichen urticatus, and psoriasis.

 

 

Jennifer Grebow
Editor-in-Chief
Nutritional Outlook magazine
jennifer.grebow@ubm.com